Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
4.480
-0.390 (-8.01%)
May 9, 2025, 4:00 PM - Market closed

Aligos Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-53.26-131.21-87.68-96.05-128.33-108.54
Upgrade
Depreciation & Amortization
2.532.623.073.683.783.33
Upgrade
Loss (Gain) From Sale of Assets
--0.02---
Upgrade
Asset Writedown & Restructuring Costs
--0.72---
Upgrade
Loss (Gain) From Sale of Investments
-1.84-1.78-0.42-0.160.090.23
Upgrade
Stock-Based Compensation
6.768.4512.6514.6913.462.98
Upgrade
Other Operating Activities
-29.8146.132.17--11.68
Upgrade
Change in Accounts Payable
1.460.05-2.221.72-0.31-0.13
Upgrade
Change in Unearned Revenue
-0.72-1.16-8.142.5-4.3612
Upgrade
Change in Other Net Operating Assets
-4.03-3.850.83-5.780.024.19
Upgrade
Operating Cash Flow
-78.91-80.74-79-79.39-115.66-74.26
Upgrade
Capital Expenditures
-0.1-0.13-0.02-0.94-0.89-2.06
Upgrade
Investment in Securities
26.4-18.1545-25.353.9134.82
Upgrade
Investing Cash Flow
26.3-18.2844.98-26.293.0232.76
Upgrade
Long-Term Debt Repaid
--0.08-0.1-0.06-0.08-0.06
Upgrade
Total Debt Repaid
-0.06-0.08-0.1-0.06-0.08-0.06
Upgrade
Net Debt Issued (Repaid)
-0.06-0.08-0.1-0.06-0.08-0.06
Upgrade
Issuance of Common Stock
102.180.4418.020.2379.63155.8
Upgrade
Other Financing Activities
--70.41--0.88-4.52
Upgrade
Financing Cash Flow
102.120.3688.330.1678.68192.35
Upgrade
Net Cash Flow
49.51-98.6754.31-105.52-33.96150.84
Upgrade
Free Cash Flow
-79.01-80.87-79.02-80.33-116.55-76.33
Upgrade
Free Cash Flow Margin
-2416.21%-2050.01%-508.83%-577.64%-2673.87%-
Upgrade
Free Cash Flow Per Share
--12.91-30.82-47.04-73.11-191.04
Upgrade
Levered Free Cash Flow
-43.25-46.99-45.91-43.65-62.76-44.6
Upgrade
Unlevered Free Cash Flow
-43.25-46.99-45.91-43.65-62.76-44.45
Upgrade
Change in Net Working Capital
0.162.216.980.09-1.1-12.46
Upgrade
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q